Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|January 26, 2022
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Bone Marrow Transplantation|July 27, 2026
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working partiesArsene Mekinian, Artem Oganesyan, Zinaida Perić, et al.
Transplantation and Cellular Therapy|November 24, 2021
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and CriticismsMichele Malagola, Nicola Polverelli, Vicky Rubini, et al.
Blood Advances|February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trialAnna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
BMJ Open Quality|July 7, 2025
Perception of 'patient safety culture' among healthcare professionals in the field of haematopoietic stem cell transplantation and CAR-T therapy: a multicentre cross-sectional observational study by Italian Transplant Group for Bone Marrow Transplantation, Haematopoietic Stem Cells and Cell Therapy (GITMO)Marco Cioce, Giuseppe Vetrugno, Angela Iula, et al.
Transplantation Direct|February 27, 2023
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld StudyMichele Malagola, Nicola Polverelli, Massimo Martino, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBTUrsula La Rocca, Roberto Ricci, Alfonso Piciocchi, et al.
Nature Medicine|April 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trialZachary D Crees, Michael P Rettig, Reyka G Jayasinghe, et al.
Transplantation and Cellular Therapy|May 9, 2021
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei TrapiantiAlessandra Picardi, Nicoletta Sacchi, Valeria Miotti, et al.
Frontiers in Oncology|October 7, 2021
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World ExperienceMassimo Martino, Annalisa Pitino, Mercedes Gori, et al.
Pageof 17